FLNA
Filana Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.82
−0.99%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-66.5%
Return on equity
-40.7%
Return on assets
-72.3%
Return on invested capital
0.00x
Asset turnover
-$32.3M
Cash from operations
$1.71
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026